Venous Thromboembolism and Its Treatment in High-Risk Groups

Semin Thromb Hemost 2003; 29: 001-002
DOI: 10.1055/s-2003-45417

PREFACE

Ajay K. Kakkar¹ , Sylvia Haas² , Mark Levine³

¹Department of Surgical Oncology and Technology, Imperial College, Hammersmith Hospital, London, United Kingdom
²Institut für Experimentelle Onkologie und Therapieforschung, Technische Universität, München, Germany
³Departments of Medicine and Clinical Epidemiology & Biostatistics, Buffett Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ontario, Canada